4//SEC Filing
Erck Stanley C 4
Accession 0001415889-24-026144
CIK 0001287098other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 4:25 PM ET
Size
9.3 KB
Accession
0001415889-24-026144
Insider Transaction Report
Form 4
MAXCYTE, INC.MXCT
Erck Stanley C
Director
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2024-11-01−47,689→ 0 totalExercise: $0.04Exp: 2024-11-11→ Common Stock (47,689 underlying) - Exercise/Conversion
Common Stock
2024-11-01$0.04/sh+47,689$1,908→ 316,807 total - Sale
Common Stock
2024-11-01$3.72/sh−47,689$177,403→ 269,118 total
Footnotes (3)
- [F1]The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024.
- [F2]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.61 to $3.755, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]This option is fully vested and exercisable.
Documents
Issuer
MAXCYTE, INC.
CIK 0001287098
Entity typeother
Related Parties
1- filerCIK 0001342826
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 4:25 PM ET
- Size
- 9.3 KB